The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Personal Beliefs Affect Medication Adherence for RA Patients

Personal Beliefs Affect Medication Adherence for RA Patients

July 10, 2015 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

GENERIC_Drugs_500x270A British study of rheumatoid arthritis (RA) patients found that 40% of those surveyed scored poorly on medication adherence, reinforcing the need to impress upon patients how important constancy is, one rheumatologist says.

You Might Also Like
  • Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do
  • Medication Adherence for Osteoporosis Prevention
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
Also By This Author
  • Small Grants Fund Physical Activity to Combat OA

Published online in May in Rheumatology, the paper, “The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: A study in the biologics era,” involved 239 patients in England who were treated with adalimumab. Low adherence was reported by 23% of respondents, with 41% of respondents reporting low adherence during at least one time period.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The variation of patients who reported currently adhering poorly to medication guidelines vs. those who admitted they had struggled with adherence at some prior point is important, says Jennifer Stichman, MD, an assistant professor of general internal medicine at Denver Health and the University of Colorado, who has written about medication adherence for The Rheumatologist.

“This [variation] reinforces that asking about adherence on a regular basis is important,” Dr. Stichman adds.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The study concluded that rheumatologists’ paying more attention to the importance of psychological factors—particularly patients’ medication beliefs—could “have substantial clinical and health economic benefits in RA.”

“It all comes down to time,” Dr. Stichman says. Rheumatologists need to take time to flesh out how patients view medication and work from there. A screening question for adherence could be added to the introductory paperwork, for example.

“Medication beliefs are not part of the usual framework we [are] taught to ask patients about their medicines,” Dr. Stichman says. “Certainly, we are trained to ask about tolerability, side effects and efficacy, and I would add that the next step is to ask about adherence. There is value to clinicians in knowing that medication beliefs influence patient behavior because it can help us modify our behavior to elicit those beliefs.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Richard Quinn is a freelance writer in New Jersey.

Reference

  1. Morgan C, McBeth J, Cordingley L, et al. The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: A study in the biologics era. Rheumatology (Oxford). 2015 May 13. pii: kev105. doi: 10.1093/rheumatology/kev105. [Epub ahead of print]

Filed Under: Conditions, Drug Updates, Rheumatoid Arthritis Tagged With: adalimumab, adherence, Medication, Rheumatiod arthritis

You Might Also Like:
  • Medication Non-Adherence by Rheumatology Patients & What Rheumatologists Can Do
  • Medication Adherence for Osteoporosis Prevention
  • High Cost of DMARDs Could Limit Medicare Patients’ Treatment Adherence
  • Research Shows High Adherence to Performance Measures for RA Cohort

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)